Selank is a synthetic peptide analogue of tuftsin, an endogenous immune-related peptide fragment. It was engineered for greater stability and is studied mainly for potential anxiolytic and cognitive effects.

What does research suggest Selank does?

Animal and mechanistic studies have reported anxiolytic-like effects and discussed possible influences on GABA and monoamine systems. Independent human evidence is limited and concentrated in a few regional research settings, so conclusions remain preliminary.

Is Selank approved or legal?

Selank is used as an approved intranasal medicine in some countries but is not approved by EU or US regulators. Legal status varies by jurisdiction, and outside its regional approvals it is generally treated as an unapproved research compound.

Its long-term safety profile is not fully established outside the regions where it is prescribed, and research-market material has unverified purity. It is not a validated treatment in most countries, and safety data should be regarded as limited.

What are the reported side effects of Selank?

Reported side effects are limited in the available literature, with nasal irritation noted in connection with intranasal use. Because independent long-term human data is sparse, the full side-effect profile is not well characterized.

How does Selank compare to Semax?

Both are Russian-developed peptides discussed in nootropic and neuropeptide research, and they are sometimes mentioned together. Selank is more associated with anxiolytic effects while Semax is discussed for cognitive and neuroprotective effects, though independent evidence for both remains limited.

Why is Selank often mentioned alongside Semax?

Both are short peptides that came out of the same Russian research lineage and are studied intranasally for brain-related effects, so hobbyist discussions frequently group them together and mention using them in combination. That pairing reflects community convention and shared origin, not evidence that the two should be combined or that doing so is validated or safe. Their research contexts differ, and being discussed together does not make either an established treatment.

Is Selank related to a natural molecule in the body?

Yes. It was designed as a synthetic analogue of tuftsin, a naturally occurring peptide fragment with immune-signaling roles. The chemical modifications were intended to make the molecule more stable than the native fragment, which breaks down quickly. Being derived from a natural peptide is a common point of confusion: it does not mean Selank itself is natural, well-characterized in humans, or free of the purity and evidence caveats that apply to any research-market compound.

Why does its legal status vary so much by country?

Selank was developed and registered as a medicine within Russia, so it exists there in a regulated pharmaceutical context. Most other regulators, including in the EU and US, have never reviewed or approved it, which is why the same compound can be a registered drug in one jurisdiction and an unapproved research chemical in another. Regional approval in one country does not imply the independent, multi-center evidence that agencies elsewhere typically require.

Where can I buy Selank and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Cognitive / Mood

Buy Selank – Vendors, Prices, Testing and Evidence

Buy Selank

Also known as: TP-7 analogue

Evidence grade C — Early / Preclinical

Short answer

An anxiolytic-discussed peptide analogue. Approved in some jurisdictions, limited independent evidence elsewhere.

Where can you buy Selank?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

Selank is a synthetic analogue of the endogenous peptide tuftsin, studied for anxiolytic effects.

What is not established?

Some regional clinical use; limited independent replication.

Safety

Research-market purity is unverified; not a validated treatment outside its regional approvals.

Regulatory status

Used as a medicine in some countries; not approved in the EU/US.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy Selank: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	Selank research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

Selank research product

Code PEPTIDES10 −10% · discount code details

What is it?

Selank is a synthetic analogue of the endogenous peptide tuftsin, studied for anxiolytic effects.

Research and evidence

Selank is a synthetic peptide developed as a stabilized analogue of tuftsin, a naturally occurring immunomodulatory fragment of the immunoglobulin G molecule. Sometimes referenced in research literature in connection with the designation TP-7, it was designed to resist rapid enzymatic breakdown in the body, giving it a longer window of activity than the parent peptide. It is most often categorized as a cognitive and mood-focused compound and is studied primarily for potential anxiolytic (anxiety-reducing) properties, which places it alongside peptides like Semax in discussions of so-called nootropic or neuropeptide research.

The scientific interest in Selank centers on how it may interact with the brain's signaling systems. Preclinical and mechanistic work has discussed possible effects on GABAergic and monoamine (serotonin and dopamine) pathways, as well as on the expression of factors related to stress and immune signaling. Animal studies have reported anxiolytic-like effects, and Selank has seen regional clinical use as an intranasally administered medicine in a small number of countries, notably within Russian pharmacology. However, independent, large-scale human replication outside those jurisdictions remains limited, which is why its overall evidence rating is best described as modest rather than well-established. Claims about memory, focus, or generalized well-being should be read against this backdrop of preliminary and geographically concentrated data.

From a regulatory and safety standpoint, the picture is nuanced. Selank is used as an approved medicine in some countries but is not approved by the EU or US regulators, and material sold on the research-chemical market has unverified purity and identity. Reported side effects are limited but include nasal irritation associated with intranasal use, and its long-term safety profile in the general population is not fully characterized. This page is an educational reference intended to summarize what the research literature does and does not show; it is not medical advice, and it does not provide dosing, protocols, or sourcing guidance. Anyone considering peptide-related decisions for health reasons should consult a qualified, licensed clinician.

Evidence grade: C

Some regional clinical use; limited independent replication. Preclinical anxiolytic effects reported.

Human evidence

Some regional clinical use; limited independent replication.

Animal and preclinical evidence

Preclinical anxiolytic effects reported.

Proposed mechanisms

Discussed effects on GABA and monoamine systems

Safety concerns and known side effects

Research-market purity is unverified; not a validated treatment outside its regional approvals.

Nasal irritation with intranasal use reported

Regulatory status

Used as a medicine in some countries; not approved in the EU/US.

Selank research timeline

1980s–1990s
Selank is designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analogue of the endogenous immunopeptide tuftsin, a heptapeptide fragment, aimed at more stable anxiolytic activity.
1990s
Early preclinical work in rodents reports anxiolytic-like and behavioral effects, and researchers describe proposed interactions with GABA and monoamine systems as a rationale for further study.
2000s
Small clinical studies, largely conducted by Russian research groups, explore intranasal use for generalized anxiety; the peptide is registered and marketed as a medicine within Russia.
2010s
Additional regional publications examine mechanisms and effects on gene expression and BDNF-related pathways, while independent replication outside the originating groups remains limited.
early 2020s
Selank remains unapproved in the EU and US and circulates internationally through the research-chemical market, where product identity and purity are not independently guaranteed.

Frequently asked questions about Selank

What is Selank?: Selank is a synthetic peptide analogue of tuftsin, an endogenous immune-related peptide fragment. It was engineered for greater stability and is studied mainly for potential anxiolytic and cognitive effects.
What does research suggest Selank does?: Animal and mechanistic studies have reported anxiolytic-like effects and discussed possible influences on GABA and monoamine systems. Independent human evidence is limited and concentrated in a few regional research settings, so conclusions remain preliminary.
Is Selank approved or legal?: Selank is used as an approved intranasal medicine in some countries but is not approved by EU or US regulators. Legal status varies by jurisdiction, and outside its regional approvals it is generally treated as an unapproved research compound.
Is Selank safe?: Its long-term safety profile is not fully established outside the regions where it is prescribed, and research-market material has unverified purity. It is not a validated treatment in most countries, and safety data should be regarded as limited.
What are the reported side effects of Selank?: Reported side effects are limited in the available literature, with nasal irritation noted in connection with intranasal use. Because independent long-term human data is sparse, the full side-effect profile is not well characterized.
How does Selank compare to Semax?: Both are Russian-developed peptides discussed in nootropic and neuropeptide research, and they are sometimes mentioned together. Selank is more associated with anxiolytic effects while Semax is discussed for cognitive and neuroprotective effects, though independent evidence for both remains limited.
Why is Selank often mentioned alongside Semax?: Both are short peptides that came out of the same Russian research lineage and are studied intranasally for brain-related effects, so hobbyist discussions frequently group them together and mention using them in combination. That pairing reflects community convention and shared origin, not evidence that the two should be combined or that doing so is validated or safe. Their research contexts differ, and being discussed together does not make either an established treatment.
Is Selank related to a natural molecule in the body?: Yes. It was designed as a synthetic analogue of tuftsin, a naturally occurring peptide fragment with immune-signaling roles. The chemical modifications were intended to make the molecule more stable than the native fragment, which breaks down quickly. Being derived from a natural peptide is a common point of confusion: it does not mean Selank itself is natural, well-characterized in humans, or free of the purity and evidence caveats that apply to any research-market compound.
Why does its legal status vary so much by country?: Selank was developed and registered as a medicine within Russia, so it exists there in a regulated pharmaceutical context. Most other regulators, including in the EU and US, have never reviewed or approved it, which is why the same compound can be a registered drug in one jurisdiction and an unapproved research chemical in another. Regional approval in one country does not imply the independent, multi-center evidence that agencies elsewhere typically require.
Where can I buy Selank and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

AnxietySleepStacking with Semax

Compare Selank

Selank vs Semax

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10